Home »

Sensors for Medicine and Science Raises $54.1 Million Series D Financing

GERMANTOWN, MD — (Marketwire) — 11/01/11 — (SMSI), a privately held medical device company focused on the development and commercialization of the first fully implantable, long-term (CGM) system for people with diabetes, announced today a $54.1 million Series D equity financing. The funding was led by new investor Delphi Ventures, with significant participation from existing investors New Enterprise Associates (NEA), HealthCare Ventures, Anthem Capital and Greenspring Associates.The Serie

Analytics

© 2020 88Finance. All Rights Reserved. Log in - Copyright by LayerMedia


Blogverzeichnis - Blog Verzeichnis bloggerei.de Blog Top Liste - by TopBlogs.de